A comparative pharmacokinetic study of recombinant human serum albumin with plasma-derived human serum albumin in patients with liver cirrhosis

Journal of Clinical Pharmacology

Volumn 48, Issue 2, 2008, Pages 203-208

  Ohnishi, Kunihiko ^a   Kawaguchi, Atsuhiro ^b   Nakajima, Shunji ^b   Mori, Hiroyuki ^b   Ueshima, Takahiro ^b  

^a Ohnishi Hospital   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Bioequivalence; Liver cirrhosis; Pharmacokinetics; Pichia pastoris; Recombinant human serum albumin

Indexed keywords

HUMAN SERUM ALBUMIN; RECOMBINANT HUMAN SERUM ALBUMIN;

ADULT; AGED; ALLERGY; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG BLOOD LEVEL; DRUG SAFETY; FEMALE; HUMAN; INSOMNIA; LABORATORY TEST; LIVER CIRRHOSIS; MALE; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; METHYLOTROPHIC YEAST; PICHIA PASTORIS; SIDE EFFECT;

AGED; AREA UNDER CURVE; BILIRUBIN; BLOOD UREA NITROGEN; CREATININE; FEMALE; HALF-LIFE; HUMANS; INFUSION PUMPS; INJECTIONS, INTRAVENOUS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PICHIA; RECOMBINANT PROTEINS; SERUM ALBUMIN; SEX FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; THERAPEUTIC EQUIVALENCY;

EID: 38349139457     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270007310549     Document Type: Article

References (26)

1. Tullis JL Albumin. Guidelines for clinical use. JAMA. 1977 ; 237: 460-463.
2. Vermeulen LC, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA A paradigm for consensus. The university hospital consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med. 1995 ; 155: 373-379.
3. Marth E., Kleinhappl B. Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination. Vaccine. 2002 ; 20: 532-537.
4. Sebeka HK, Starkuviene B., Trepsiene OV, Pauliukonis AA, Bumelis VA Comparative effects of stabilizing additives on the rates of heat inactivation of recombinant human interferon alpha-2b in solution. Antiviral Res. 2001 ; 50: 117-127.
5. Matejtschuk P., Dash CH, Gascoigne EW Production of human albumin solution: a continually developing colloid. Br J Anaesth. 2000 ; 85: 887-895.
6. Saunders CW, Schmidt BJ, Mallonee RL, Guyer MS Secretion of human serum albumin from Bacillus subtilis. J Bacteriol. 1987 ; 169: 2917-2925.
7. Sleep D., Belfield GP, Ballance DJ, et al. Saccharomyces cerevisiae strains that overexpress heterologous proteins. Biotechnol. 1991 ; 9: 183-187.
8. Bosse D., Praus M., Kiessling P., et al. Phase I comparability of recombinant human albumin and human serum albumin. J Clin Pharmacol. 2005 ; 45: 57-67.
9. Watanabe H., Yamasaki K., Kragh-Hansen U., Tanase S., Harada K., Suenaga A. et al. In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time. Pharm Res. 2001 ; 18: 1775-1781.
10. Kobayashi K., Kuwae S., Ohya T., et al. High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation. J Biosci Bioeng. 2000 ; 89: 55-61.
11. Sumi A., Okuyama K., Kobayashi K., Ohtani W., Ohmura T., Yokoyama K. Purification of recombinant human serum albumin efficient purification using STREAMLINE. Bioseparation. 1999 ; 8: 195-200.
12. Ohtani W., Ohda T., Sumi A., Kobayashi K., Ohmura T. Analysis of Pichia pastoris components in recombinant human serum albumin by immunological assays and by HPLC with pulsed amperometric detection. Anal Chem. 1998 ; 70: 425-429.
13. Ohtani W., Masaki A., Ikeda Y., et al. Structure of recombinant human serum albumin from Pichia pastoris. Yakugaku Zasshi. 1997 ; 117: 220-232.
14. Ikegaya K., Hirose M., Ohmura T., Nokihara K. Complete determination of disulfide forms of purified recombinant human serum albumin, secreted by the yeast Pichia pastoris. Anal Chem. 1997 ; 69: 1986-1991.
15. Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K. Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng. 1999 ; 12: 439-446.
16. Ohtani W., Nawa Y., Takeshima K., Kamuro H., Kobayashi K., Ohmura T. Physicochemical and immunochemical properties of recombinant human serum albumin from Pichia pastoris. Anal Biochem. 1998 ; 256: 56-62.
17. Okano K., Ohkubo M., Sogame Y., et al. Metabolic fate of recombinant human serum albumin (rHSA)(1)-Plasma concentration after a single or repeated intravenous administration of 125I-rHSA to rats and dogs. Jpn Pharmacol Ther. 1997 ; 25 (Suppl 8). 197-205.
18. Okano K., Sogame Y., Ohkubo M., Haruta T., Tsuda Y. Metabolic fate of recombinant human serum albumin (rHSA)(2)- Distribution, metabolism, and excretion of rHSA after a single or repeated intravenous administration of 125I-rHSA to rats and excretion after a single intravenous administration of 125I-rHSA to dogs. Jpn Pharmacol Ther. 1997 ; 25 (Suppl 8). 207-218.
19. Kamata T., Toda G., Kasahara A., Uematsu M., Hanaoka K., Yuasa S. Multicenter group comparative study of GB-1057 [human serum albumin (recombinant)] and plasma-derived human serum albumin for the treatment of ascites due to liver cirrhosis [in Japanese]. The Japanese Journal of Clinical and Experimental Medicine. 1997 ; 74: 2884-2899.
20. Kobayashi K. Summary of recombinant human serum albumin development. Biologicals. 2006 ; 34: 55-59.
21. Peters TJ Metabolism: albumin in the body. In: Peters TJ (ed). All About Albumin: Biochemistry, Genetics, and Medical Applications. San Diego, CA: Academic Press Inc. ; 1996: 188-250.
22. Beeken WL, Volwiler W., Goldsworthy PD, et al. Studies of I131albumin catabolism and distribution in normal young male adults. J Clin Invest. 1962 ; 41: 1312-1333.
23. Dixon FJ, Maurer PH, Deichmiller MP Half-lives of homologous serum albumins in several species. Proc Soc Exp Biol Med. 1953 ; 83: 287-288.
24. Guidelines for Bioequivalence Testing of Generic Drugs. Notification No. 786 of the Evaluation and Licensing Division, Pharmaceutical and Medical Safety Bureau, The Ministry of Health, Labour and Welfare, Japan (May 31, 2001 ).
25. Runyon BA Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Management of adult patients with ascites due to cirrhosis. Hepatology. 2004 ; 39: 841-856.
26. Kato M., Yoshida T., Moriwaki H., Muto Y. Effect of branched-chain amino acid (BCAA) enriched-nutrient mixture on albumin metabolism in cirrhotic patients [in Japanese]. Kanzou. 1991 ; 32: 692-699.